These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12537700)

  • 21. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting.
    Cantwell K; Dietze P; Flander L
    Resuscitation; 2005 Jun; 65(3):315-9. PubMed ID: 15919568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose.
    Dietze P; Jolley D; Fry C; Bammer G
    Addiction; 2005 May; 100(5):636-42. PubMed ID: 15847621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose.
    Galea S; Nandi A; Coffin PO; Tracy M; Markham Piper T; Ompad D; Vlahov D
    J Addict Dis; 2006; 25(3):79-87. PubMed ID: 16956872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of a heroin overdose prevention and education campaign.
    Horyniak D; Higgs P; Lewis J; Winter R; Dietze P; Aitken C
    Drug Alcohol Rev; 2010 Jan; 29(1):5-11. PubMed ID: 20078676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Sep; 24(5):425-32. PubMed ID: 16298837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity associated with heroin overdose presentations to an emergency department: a 10-year record linkage study.
    Fatovich DM; Bartu A; Davis G; Atrie J; Daly FF
    Emerg Med Australas; 2010 Jun; 22(3):240-5. PubMed ID: 20590786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overdose after detoxification: a prospective study.
    Wines JD; Saitz R; Horton NJ; Lloyd-Travaglini C; Samet JH
    Drug Alcohol Depend; 2007 Jul; 89(2-3):161-9. PubMed ID: 17280803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonfatal heroin overdoses in Queensland, Australia: an analysis of ambulance data.
    Clark MJ; Bates AC
    J Urban Health; 2003 Jun; 80(2):238-47. PubMed ID: 12791800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention.
    Davidson PJ; McLean RL; Kral AH; Gleghorn AA; Edlin BR; Moss AR
    J Urban Health; 2003 Jun; 80(2):261-73. PubMed ID: 12791802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
    Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time surveillance of illicit drug overdoses using poison center data.
    Friedman LS
    Clin Toxicol (Phila); 2009 Jul; 47(6):573-9. PubMed ID: 19566385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdoses among friends: drug users are willing to administer naloxone to others.
    Lagu T; Anderson BJ; Stein M
    J Subst Abuse Treat; 2006 Mar; 30(2):129-33. PubMed ID: 16490676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heroin related overdose problems].
    Skulberg A; Hansen TB; Cron RD; Sundelius J
    Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1363-5. PubMed ID: 8337627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia.
    Lenton SR; Dietze PM; Degenhardt L; Darke S; Butler TG
    Drug Alcohol Rev; 2009 Nov; 28(6):583-5. PubMed ID: 19930009
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims.
    Darke S; Duflou J; Kaye S
    Addiction; 2007 Nov; 102(11):1793-7. PubMed ID: 17784895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.